Sector: Services-Commercial Physical & Biological Research · Industry: Diagnostics & Research · Exchange: Nasdaq
Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, Asia, South America, Africa, and Australia. The company offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. It provides clinical development services to the pharmaceutical, biotechnology, and medical device industries; and development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support services. In addition, the company offers bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. Medpace Holdings, Inc. was founded in 1992 and is based in Cincinnati, Ohio.
Headquarters: Cincinnati, OH · Employees: 6300 · Website: https://www.medpace.com
Medpace Holdings, Inc. (MEDP) is a publicly traded company in the Services-Commercial Physical & Biological Research sector (Diagnostics & Research), listed on Nasdaq. Macroplane maps its supply-chain relationships, suppliers, buyers, financial health, and competitive positioning.
Competitors of Medpace Holdings, Inc. (MEDP) tracked by Macroplane include ELI LILLY & Co (LLY), JOHNSON & JOHNSON (JNJ), AbbVie Inc. (ABBV), Merck & Co., Inc. (MRK), NOVO NORDISK A S (NVO), AMGEN INC (AMGN), PFIZER INC (PFE), Bayer Aktiengesellschaft (1BAYN.MI), and 4 more.
Search companies · Macro trends · Industries · Product categories · Baskets